MRK-740
Product Specifications
UNSPSC Description
MRK-740 is a potent, selective and substrate-competitive PRDM9 histone methyltransferase inhibitor with an IC50 of 80 nM. MRK-740 is more selective for PRDM9 than other histone methyltransferases and other non-epigenetic targets. MRK-740 reduces PRDM9-dependent trimethylation of H3K4 (IC50 = 0.8 µM)[1].
Target Antigen
Histone Methyltransferase
Type
Reference compound
Related Pathways
Epigenetics
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/mrk-740.html
Purity
99.84
Solubility
DMSO : 40 mg/mL (ultrasonic;warming)
Smiles
CC1=NC=CC(N(CC2)CCC32CN(C4=NC(C5=CC(OC)=CC(OC)=C5)=NO4)CCN3C)=C1
Molecular Weight
464.56
References & Citations
[1]Abdellah Allali-Hassani, et al. Discovery of a Chemical Probe for PRDM9. Nat Commun. 2019 Dec 17;10(1):5759.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-114209/MRK-740-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-114209/MRK-740-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
2387510-80-5
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6298889-01 0.2 mL
FFAR1, CT (FFAR1, GPR40, Free fatty acid receptor 1, G-protein coupled receptor 40) (PE)
Ask
View Details 
MBS6298889-02 5x 0.2 mL
FFAR1, CT (FFAR1, GPR40, Free fatty acid receptor 1, G-protein coupled receptor 40) (PE)
Ask
View Details